Ef cacy and safety of feno brate add-on therapy in patients with primary biliary cholangitis refractory to ursodeoxycholic acid: a retrospective study and updated meta-analysis

HIGHLIGHTS

• who: August et al. from the University of Medicine and Pharmacy of (CAMS), China have published the research work: Ef cacy and safety of feno brate add-on therapy in patients with primary biliary cholangitis refractory to ursodeoxycholic acid: A retrospective study and updated meta-analysis, in the Journal: (JOURNAL)
• what: In the current study, the researchers evaluated the included studies based on the following seven dimensions: 1.
• how: The included studies were identified in English databases including PubMed Embase and 2) PBC was diagnosed when any two of the following three criteria . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.